echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Recommended reading: Chinese expert consensus on the triple optimization of oral hypoglycemic drugs for adult patients with type 2 diabetes mellitus (metformin + dipeptidyl peptidase 4 inhibitor + SLG-2 inhibitor).

    Recommended reading: Chinese expert consensus on the triple optimization of oral hypoglycemic drugs for adult patients with type 2 diabetes mellitus (metformin + dipeptidyl peptidase 4 inhibitor + SLG-2 inhibitor).

    • Last Update: 2022-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Guide name: Chinese expert consensus on the triple optimization scheme of oral hypoglycemic drugs (metformin + dipeptidyl peptidase 4 inhibitor + sodium⁃glucose cotransporter 2 inhibitor) for adult patients with type 2 diabetes

    English:

    Published by: China Research Hospital Association (CRHA, Chinese Research Hospital Association)

    Published: 2021-08-20

    Brief introduction:

    Source: Chinese Journal of Diabetes

    Download address: Please download the Mace Medical APP to download (Mace Medical APP points download)
    Tips: 78% of users have downloaded the Mace Medical APP, which is more convenient to read and communicate, please scan the QR code to download the APP directly

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.